Journal
Blood Advances
Publication Date
2016
Volume
1
Issue
2
Inclusive Pages
122-131
Document Type
Open Access Publication
DOI
https://doi.org/10.1182/bloodadvances.2016000976
Rights and Permissions
de Vos, S., Wagner-Johnston, N. D., Coutre, S. E., Flinn, I. W., Schreeder, M. T., Fowler, N. H., Sharman, J. P., Boccia, R. V., Barrientos, J. C., Rai, K. R., Boyd, T. E., Furman, R. R., Kim, Y., Godfrey, W. R., & Leonard, J. P. (2016). Combinations of idelalisib with rituximab and/or bendamustine in patients with recurrent indolent non-Hodgkin lymphoma. Blood Advances, 1(2), 122-131. https://doi.org/10.1182/bloodadvances.2016000976.
Recommended Citation
de Vos, Sven; Wagner-Johnston, Nina D.; Coutre, Steven E.; Flinn, Ian W.; Schreeder, Marshall T.; Fowler, Nathan H.; Sharman, Jeff P.; Boccia, Ralph V.; Barrientos, Jacqueline C.; Rai, Kanti R.; Boyd, Thomas E.; Furman, Richard R.; Kim, Yeonhee; Godfrey, Wayne R.; and Leonard, John P., "Combinations of idelalisib with rituximab and/or bendamustine in patients with recurrent indolent non-Hodgkin lymphoma." Blood Advances. 1, 2. 122-131. (2016).
https://digitalcommons.wustl.edu/open_access_pubs/7229
